Tag: GlobeNewswire

Greenwich, CT, Oct. 02, 2026 (GLOBE NEWSWIRE) — Southport Acquisition Corp. II (NYSE: PORT.U) (the “Company”) today announced the closing of the Company’s initial public offering of 21,000,000 units, which includes 1,000,000 units issued pursuant to the partial exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit.

The Company’s units began trading on the New York Stock Exchange (“NYSE”) on October 1, 2026, under the ticker symbol “PORT.U.” Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “PORT” and “PORT.W,” respectively.

Cohen & Company Capital Markets acted as the sole book-running manager for the offering. Ellenoff Grossman & Schole LLP and Ogier (Cayman) LLP served as legal counsel to the Company, and Reed Smith LLP served as legal counsel to the underwriters.

A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission (the “SEC”) on September 30, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering was made only by means of a prospectus, copies of which may be obtained from Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: capitalmarkets@cohencm.com. Copies of the registration statement can be accessed for free through the SEC’s website at www.sec.gov.

Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $212,100,000 was placed in the Company’s trust account for the benefit of the Company’s public shareholders. An audited balance sheet of the Company as of October 2, 2026 reflecting receipt of the proceeds upon consummation of the initial public offering and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the SEC.

About Southport Acquisition Corp. II

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination target in any business, industry, sector or geographical location. The Company’s management team is led by Jeb Spencer, its Chief Executive Officer and Chairman of the Board of Directors, and Griffith Gates, its President and Chief Operating Officer. Jared Stone, Matthew Hansen, David Winfield, Cathleen Schreiner-Gates, John Aslanian and Robert Katz are independent directors.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the search for an initial business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.

Contact Information:

Southport Acquisition Corp. II
Jeb Spencer, Chief Executive Officer
jspencer@tvccapital.com 

Greenwich, CT, Oct. 02, 2026 (GLOBE NEWSWIRE) — Southport Acquisition Corp. II (NYSE: PORT.U) (the “Company”) today announced the closing of the Company’s initial public offering of 21,000,000 units, which includes 1,000,000 units issued pursuant to the partial exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit.

The Company’s units began trading on the New York Stock Exchange (“NYSE”) on October 1, 2026, under the ticker symbol “PORT.U.” Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “PORT” and “PORT.W,” respectively.

Cohen & Company Capital Markets acted as the sole book-running manager for the offering. Ellenoff Grossman & Schole LLP and Ogier (Cayman) LLP served as legal counsel to the Company, and Reed Smith LLP served as legal counsel to the underwriters.

A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission (the “SEC”) on September 30, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering was made only by means of a prospectus, copies of which may be obtained from Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: capitalmarkets@cohencm.com. Copies of the registration statement can be accessed for free through the SEC’s website at www.sec.gov.

Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $212,100,000 was placed in the Company’s trust account for the benefit of the Company’s public shareholders. An audited balance sheet of the Company as of October 2, 2026 reflecting receipt of the proceeds upon consummation of the initial public offering and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the SEC.

About Southport Acquisition Corp. II

The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination target in any business, industry, sector or geographical location. The Company’s management team is led by Jeb Spencer, its Chief Executive Officer and Chairman of the Board of Directors, and Griffith Gates, its President and Chief Operating Officer. Jared Stone, Matthew Hansen, David Winfield, Cathleen Schreiner-Gates, John Aslanian and Robert Katz are independent directors.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the search for an initial business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.

Contact Information:

Southport Acquisition Corp. II
Jeb Spencer, Chief Executive Officer
jspencer@tvccapital.com 

WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation

WISeSat.Space Ordinary Shares Begin Trading on Nasdaq Under Ticker Symbol “SAIQ”

Listing Marks a New Chapter in WISeSat.Space’s Mission to Bring Cybersecurity to Space and Deliver Trusted Satellite Connectivity

Zug, Switzerland, October 2, 2026 – WISeQey Corp. (formerly known as WISeKey International Holding AG, “WISeQey” or the “Company”) (SIX: WIHN; Nasdaq: WKEY), a global quantum cybersecurity and space IoT company, today announced that its subsidiary WISeSat.Space Holdings Corp. (“WISeSat.Space”) (Nasdaq: SAIQ) has completed its previously announced business combination with Columbus Acquisition Corp. (“CAC”).

Effective today, October 2, 2026, WISeSat.Space ordinary shares have commenced trading on the Nasdaq Capital Market under the ticker symbol “SAIQ.”

The completion of the transaction establishes WISeSat.Space as a separately listed public company focused on post-quantum-secure satellite communications and Internet of Things connectivity. CAC shareholders approved the business combination at an extraordinary general meeting on September 30, 2026, and the transaction closed on October 1, 2026.

The Nasdaq listing supports WISeSat.Space’s ambition to expand its space infrastructure while leveraging WISeQey’s expertise in cybersecurity, digital identity and secure semiconductors. WISeSat.Space aims to extend trusted connectivity beyond terrestrial networks, enabling connected devices to communicate securely through satellite infrastructure.

“The Nasdaq listing represents an extraordinary milestone for WISeSat.Space and for everyone who has contributed to this journey,” said Carlos Moreira, Chief Executive Officer of WISeQey and WISeSat.Space. “I want to thank our employees, management team, technology partners, advisors, investors and all those whose dedication has made this achievement possible. Their commitment has helped turn our vision of bringing cybersecurity to space into a growing business.”

Mr. Moreira continued: “As more devices and essential services rely on satellite connectivity, trust and post-quantum security must be built into the infrastructure from the outset. Our ambition is to combine satellite communications with digital identity, secure chips and post-quantum technologies to help protect data from the connected device to the space network. This listing opens a new chapter in advancing that mission.”

Bringing Cybersecurity to Space
WISeSat.Space has deployed satellites into orbit since 2024 and is developing satellite connectivity designed to support secure communications for connected devices, including applications in remote monitoring, logistics, defense, and infrastructure management.

Working within the WISeKey technology ecosystem, including collaboration with it sister company SEALSQ Corp (Nasdaq: LAES), WISeSat.Space aims to integrate hardware-based security, device authentication and post-quantum protection into its satellite communications architecture. These capabilities are intended to help address both today’s cybersecurity threats and the evolving risks associated with future quantum computing.

Advisors
Maxim Group LLC served as WISeSat.Space’s financial advisor. Ellenoff Grossman & Schole LLP represented WISeSat.Space as legal counsel and Harney Westwood & Riegels (BVI) LP represented WISeSat.Space as British Virgin Islands legal counsel. Loeb & Loeb LLP represented CAC as legal counsel and Ogier represented CAC as Cayman legal counsel. The Equity Group, Inc., served as WISeSat.Space’s strategic communications advisor.

About WISeSat.Space
WISeSat.Space Holdings Corp. is a space technology company focused on secure satellite communications for Internet of Things applications. Its approach combines satellite infrastructure with cybersecurity and digital identity technologies to support trusted communications between connected devices and ground-based systems.

About WISeQey

WISeQey Corp. (“WISeQey”), is a British Virgin Islands holding company focused on post quantum cybersecurity, digital identity, space technology and the Internet of Things (IoT). Its operating subsidiaries and technology platforms address distinct parts of this portfolio:

1. SEALSQ Corp (Nasdaq: LAES) develops secure semiconductors, public key infrastructure (PKI) and post-quantum security products.
2. WISeSat AG develops space technology and secure satellite communications, particularly for IoT applications.
3. WISeID provides digital identity, authentication, secure access and digital signing for individuals, enterprises and connected devices.
4. WISe.ART Corp operates the WISe.ART marketplace, which uses blockchain technology to support trusted digital asset and NFT transactions.
5. SEALCOIN AG develops decentralized physical infrastructure network (DePIN) technology and the SEALCOIN platform.

Each subsidiary contributes to WISeQey’s mission of securing the internet while focusing on their respective areas of research and expertise. Their technologies seamlessly integrate into the comprehensive WISeQey platform. WISeQey secures digital identity ecosystems for individuals and objects using blockchain, AI, and IoT technologies. With over 1.6 billion microchips deployed across various IoT sectors, WISeQey plays a vital role in securing the Internet of Everything. Trusted by the OISTE/WISeQey cryptographic Root of Trust, WISeQey provides secure authentication and identification for IoT, blockchain, and AI applications. The WISeQey Root of Trust ensures the integrity of online transactions between objects and people. For more information on WISeQey’s strategic direction and its subsidiary companies, please visit www.wisekey.com.

Forward-Looking Statements

This communication expressly or implicitly contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning WISeQey, WISeSat.Space and their respective businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, the anticipated benefits of the business combination, WISeSat.Space’s plans to expand its satellite infrastructure and develop post-quantum-secure satellite communications, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Words such as “aims,” “ambition,” “anticipates,” “expects,” “intends,” “plans,” “will” and similar expressions are intended to identify forward-looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include WISeQey’s ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; WISeSat.Space’s ability to realize the anticipated benefits of the business combination, operate as a public company and maintain its Nasdaq listing; the success, cost and timing of satellite launches and operations; competition in the satellite and cybersecurity markets; and the risks discussed in WISeQey’s and WISeSat.Space’s filings with the SEC. Risks and uncertainties are further described in reports filed by WISeQey and WISeSat.Space with the SEC. WISeQey is providing this communication as of this date and do not undertake to update any forward-looking statements as a result of new information, future events or otherwise

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of the Swiss Financial Services Act (“FinSA”), the FinSA’s predecessor legislation or advertising within the meaning of the FinSA. Investors must rely on their own evaluation of WISeQey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeQey. Given the risks and uncertainties described herein, you should not place undue reliance on forward-looking statements as a prediction of actual results.

Press and Investor Contacts

WISeQey Corp. Company Contact: Carlos Moreira Chairman & CEO Tel: +41 22 594 3000 info@wisekey.com

WISeQey Investor Relations (US)  The Equity Group Inc. Lena Cati Tel: +1 212 836-9611 lena.cati@theequitygroup.com

WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation

WISeSat.Space Ordinary Shares Begin Trading on Nasdaq Under Ticker Symbol “SAIQ”

Listing Marks a New Chapter in WISeSat.Space’s Mission to Bring Cybersecurity to Space and Deliver Trusted Satellite Connectivity

Zug, Switzerland, October 2, 2026 – WISeQey Corp. (formerly known as WISeKey International Holding AG, “WISeQey” or the “Company”) (SIX: WIHN; Nasdaq: WKEY), a global quantum cybersecurity and space IoT company, today announced that its subsidiary WISeSat.Space Holdings Corp. (“WISeSat.Space”) (Nasdaq: SAIQ) has completed its previously announced business combination with Columbus Acquisition Corp. (“CAC”).

Effective today, October 2, 2026, WISeSat.Space ordinary shares have commenced trading on the Nasdaq Capital Market under the ticker symbol “SAIQ.”

The completion of the transaction establishes WISeSat.Space as a separately listed public company focused on post-quantum-secure satellite communications and Internet of Things connectivity. CAC shareholders approved the business combination at an extraordinary general meeting on September 30, 2026, and the transaction closed on October 1, 2026.

The Nasdaq listing supports WISeSat.Space’s ambition to expand its space infrastructure while leveraging WISeQey’s expertise in cybersecurity, digital identity and secure semiconductors. WISeSat.Space aims to extend trusted connectivity beyond terrestrial networks, enabling connected devices to communicate securely through satellite infrastructure.

“The Nasdaq listing represents an extraordinary milestone for WISeSat.Space and for everyone who has contributed to this journey,” said Carlos Moreira, Chief Executive Officer of WISeQey and WISeSat.Space. “I want to thank our employees, management team, technology partners, advisors, investors and all those whose dedication has made this achievement possible. Their commitment has helped turn our vision of bringing cybersecurity to space into a growing business.”

Mr. Moreira continued: “As more devices and essential services rely on satellite connectivity, trust and post-quantum security must be built into the infrastructure from the outset. Our ambition is to combine satellite communications with digital identity, secure chips and post-quantum technologies to help protect data from the connected device to the space network. This listing opens a new chapter in advancing that mission.”

Bringing Cybersecurity to Space
WISeSat.Space has deployed satellites into orbit since 2024 and is developing satellite connectivity designed to support secure communications for connected devices, including applications in remote monitoring, logistics, defense, and infrastructure management.

Working within the WISeKey technology ecosystem, including collaboration with it sister company SEALSQ Corp (Nasdaq: LAES), WISeSat.Space aims to integrate hardware-based security, device authentication and post-quantum protection into its satellite communications architecture. These capabilities are intended to help address both today’s cybersecurity threats and the evolving risks associated with future quantum computing.

Advisors
Maxim Group LLC served as WISeSat.Space’s financial advisor. Ellenoff Grossman & Schole LLP represented WISeSat.Space as legal counsel and Harney Westwood & Riegels (BVI) LP represented WISeSat.Space as British Virgin Islands legal counsel. Loeb & Loeb LLP represented CAC as legal counsel and Ogier represented CAC as Cayman legal counsel. The Equity Group, Inc., served as WISeSat.Space’s strategic communications advisor.

About WISeSat.Space
WISeSat.Space Holdings Corp. is a space technology company focused on secure satellite communications for Internet of Things applications. Its approach combines satellite infrastructure with cybersecurity and digital identity technologies to support trusted communications between connected devices and ground-based systems.

About WISeQey

WISeQey Corp. (“WISeQey”), is a British Virgin Islands holding company focused on post quantum cybersecurity, digital identity, space technology and the Internet of Things (IoT). Its operating subsidiaries and technology platforms address distinct parts of this portfolio:

1. SEALSQ Corp (Nasdaq: LAES) develops secure semiconductors, public key infrastructure (PKI) and post-quantum security products.
2. WISeSat AG develops space technology and secure satellite communications, particularly for IoT applications.
3. WISeID provides digital identity, authentication, secure access and digital signing for individuals, enterprises and connected devices.
4. WISe.ART Corp operates the WISe.ART marketplace, which uses blockchain technology to support trusted digital asset and NFT transactions.
5. SEALCOIN AG develops decentralized physical infrastructure network (DePIN) technology and the SEALCOIN platform.

Each subsidiary contributes to WISeQey’s mission of securing the internet while focusing on their respective areas of research and expertise. Their technologies seamlessly integrate into the comprehensive WISeQey platform. WISeQey secures digital identity ecosystems for individuals and objects using blockchain, AI, and IoT technologies. With over 1.6 billion microchips deployed across various IoT sectors, WISeQey plays a vital role in securing the Internet of Everything. Trusted by the OISTE/WISeQey cryptographic Root of Trust, WISeQey provides secure authentication and identification for IoT, blockchain, and AI applications. The WISeQey Root of Trust ensures the integrity of online transactions between objects and people. For more information on WISeQey’s strategic direction and its subsidiary companies, please visit www.wisekey.com.

Forward-Looking Statements

This communication expressly or implicitly contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning WISeQey, WISeSat.Space and their respective businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, the anticipated benefits of the business combination, WISeSat.Space’s plans to expand its satellite infrastructure and develop post-quantum-secure satellite communications, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Words such as “aims,” “ambition,” “anticipates,” “expects,” “intends,” “plans,” “will” and similar expressions are intended to identify forward-looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include WISeQey’s ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; WISeSat.Space’s ability to realize the anticipated benefits of the business combination, operate as a public company and maintain its Nasdaq listing; the success, cost and timing of satellite launches and operations; competition in the satellite and cybersecurity markets; and the risks discussed in WISeQey’s and WISeSat.Space’s filings with the SEC. Risks and uncertainties are further described in reports filed by WISeQey and WISeSat.Space with the SEC. WISeQey is providing this communication as of this date and do not undertake to update any forward-looking statements as a result of new information, future events or otherwise

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of the Swiss Financial Services Act (“FinSA”), the FinSA’s predecessor legislation or advertising within the meaning of the FinSA. Investors must rely on their own evaluation of WISeQey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeQey. Given the risks and uncertainties described herein, you should not place undue reliance on forward-looking statements as a prediction of actual results.

Press and Investor Contacts

WISeQey Corp. Company Contact: Carlos Moreira Chairman & CEO Tel: +41 22 594 3000 info@wisekey.com

WISeQey Investor Relations (US)  The Equity Group Inc. Lena Cati Tel: +1 212 836-9611 lena.cati@theequitygroup.com

WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation

WISeSat.Space Ordinary Shares Begin Trading on Nasdaq Under Ticker Symbol “SAIQ”

Listing Marks a New Chapter in WISeSat.Space’s Mission to Bring Cybersecurity to Space and Deliver Trusted Satellite Connectivity

Zug, Switzerland, October 2, 2026 – WISeQey Corp. (formerly known as WISeKey International Holding AG, “WISeQey” or the “Company”) (SIX: WIHN; Nasdaq: WKEY), a global quantum cybersecurity and space IoT company, today announced that its subsidiary WISeSat.Space Holdings Corp. (“WISeSat.Space”) (Nasdaq: SAIQ) has completed its previously announced business combination with Columbus Acquisition Corp. (“CAC”).

Effective today, October 2, 2026, WISeSat.Space ordinary shares have commenced trading on the Nasdaq Capital Market under the ticker symbol “SAIQ.”

The completion of the transaction establishes WISeSat.Space as a separately listed public company focused on post-quantum-secure satellite communications and Internet of Things connectivity. CAC shareholders approved the business combination at an extraordinary general meeting on September 30, 2026, and the transaction closed on October 1, 2026.

The Nasdaq listing supports WISeSat.Space’s ambition to expand its space infrastructure while leveraging WISeQey’s expertise in cybersecurity, digital identity and secure semiconductors. WISeSat.Space aims to extend trusted connectivity beyond terrestrial networks, enabling connected devices to communicate securely through satellite infrastructure.

“The Nasdaq listing represents an extraordinary milestone for WISeSat.Space and for everyone who has contributed to this journey,” said Carlos Moreira, Chief Executive Officer of WISeQey and WISeSat.Space. “I want to thank our employees, management team, technology partners, advisors, investors and all those whose dedication has made this achievement possible. Their commitment has helped turn our vision of bringing cybersecurity to space into a growing business.”

Mr. Moreira continued: “As more devices and essential services rely on satellite connectivity, trust and post-quantum security must be built into the infrastructure from the outset. Our ambition is to combine satellite communications with digital identity, secure chips and post-quantum technologies to help protect data from the connected device to the space network. This listing opens a new chapter in advancing that mission.”

Bringing Cybersecurity to Space
WISeSat.Space has deployed satellites into orbit since 2024 and is developing satellite connectivity designed to support secure communications for connected devices, including applications in remote monitoring, logistics, defense, and infrastructure management.

Working within the WISeKey technology ecosystem, including collaboration with it sister company SEALSQ Corp (Nasdaq: LAES), WISeSat.Space aims to integrate hardware-based security, device authentication and post-quantum protection into its satellite communications architecture. These capabilities are intended to help address both today’s cybersecurity threats and the evolving risks associated with future quantum computing.

Advisors
Maxim Group LLC served as WISeSat.Space’s financial advisor. Ellenoff Grossman & Schole LLP represented WISeSat.Space as legal counsel and Harney Westwood & Riegels (BVI) LP represented WISeSat.Space as British Virgin Islands legal counsel. Loeb & Loeb LLP represented CAC as legal counsel and Ogier represented CAC as Cayman legal counsel. The Equity Group, Inc., served as WISeSat.Space’s strategic communications advisor.

About WISeSat.Space
WISeSat.Space Holdings Corp. is a space technology company focused on secure satellite communications for Internet of Things applications. Its approach combines satellite infrastructure with cybersecurity and digital identity technologies to support trusted communications between connected devices and ground-based systems.

About WISeQey

WISeQey Corp. (“WISeQey”), is a British Virgin Islands holding company focused on post quantum cybersecurity, digital identity, space technology and the Internet of Things (IoT). Its operating subsidiaries and technology platforms address distinct parts of this portfolio:

1. SEALSQ Corp (Nasdaq: LAES) develops secure semiconductors, public key infrastructure (PKI) and post-quantum security products.
2. WISeSat AG develops space technology and secure satellite communications, particularly for IoT applications.
3. WISeID provides digital identity, authentication, secure access and digital signing for individuals, enterprises and connected devices.
4. WISe.ART Corp operates the WISe.ART marketplace, which uses blockchain technology to support trusted digital asset and NFT transactions.
5. SEALCOIN AG develops decentralized physical infrastructure network (DePIN) technology and the SEALCOIN platform.

Each subsidiary contributes to WISeQey’s mission of securing the internet while focusing on their respective areas of research and expertise. Their technologies seamlessly integrate into the comprehensive WISeQey platform. WISeQey secures digital identity ecosystems for individuals and objects using blockchain, AI, and IoT technologies. With over 1.6 billion microchips deployed across various IoT sectors, WISeQey plays a vital role in securing the Internet of Everything. Trusted by the OISTE/WISeQey cryptographic Root of Trust, WISeQey provides secure authentication and identification for IoT, blockchain, and AI applications. The WISeQey Root of Trust ensures the integrity of online transactions between objects and people. For more information on WISeQey’s strategic direction and its subsidiary companies, please visit www.wisekey.com.

Forward-Looking Statements

This communication expressly or implicitly contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning WISeQey, WISeSat.Space and their respective businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, the anticipated benefits of the business combination, WISeSat.Space’s plans to expand its satellite infrastructure and develop post-quantum-secure satellite communications, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Words such as “aims,” “ambition,” “anticipates,” “expects,” “intends,” “plans,” “will” and similar expressions are intended to identify forward-looking statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include WISeQey’s ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; WISeSat.Space’s ability to realize the anticipated benefits of the business combination, operate as a public company and maintain its Nasdaq listing; the success, cost and timing of satellite launches and operations; competition in the satellite and cybersecurity markets; and the risks discussed in WISeQey’s and WISeSat.Space’s filings with the SEC. Risks and uncertainties are further described in reports filed by WISeQey and WISeSat.Space with the SEC. WISeQey is providing this communication as of this date and do not undertake to update any forward-looking statements as a result of new information, future events or otherwise

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of the Swiss Financial Services Act (“FinSA”), the FinSA’s predecessor legislation or advertising within the meaning of the FinSA. Investors must rely on their own evaluation of WISeQey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeQey. Given the risks and uncertainties described herein, you should not place undue reliance on forward-looking statements as a prediction of actual results.

Press and Investor Contacts

WISeQey Corp. Company Contact: Carlos Moreira Chairman & CEO Tel: +41 22 594 3000 info@wisekey.com

WISeQey Investor Relations (US)  The Equity Group Inc. Lena Cati Tel: +1 212 836-9611 lena.cati@theequitygroup.com

CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) — Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced that on October 1, 2026, the compensation committee of Apnimed’s board of directors granted 19 new non-executive employees non-qualified stock options to purchase an aggregate of 481,300 shares of the Company’s common stock under Apnimed’s 2026 Inducement Plan (the “Plan”). Each stock option granted has an exercise price per share of $22.54, which is equal to Apnimed’s closing trading price on the grant date. One-fourth of the shares underlying each of the employee’s stock options will vest on the first anniversary of each employee’s start date and in equal monthly installments thereafter for the next three years, subject to such employee’s continued employment with the Company on such vesting dates.

The above-described awards were granted as an inducement material to such employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted pursuant to the terms of the Plan. The Plan was adopted by Apnimed’s board of directors on August 21, 2026.

About Apnimed, Inc.

Apnimed is a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases. Apnimed believes the introduction of once-nightly oral drugs has the potential to expand diagnosis and the reach of treatment for people with obstructive sleep apnea (“OSA”). Apnimed believes that people with OSA would benefit from having multiple drugs with differing mechanisms to more fully address the heterogeneity of OSA’s disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment and help more people get the oxygen and restorative sleep needed to thrive.

Apnimed is advancing its product candidate, AD109, designed to improve oxygenation in individuals living with OSA. Apnimed believes that AD109 could become the catalyst for a new oral treatment paradigm for OSA that has been historically limited to cumbersome devices or invasive surgeries. AD109 has completed two Phase 3 clinical trials for the treatment of mild, moderate and severe OSA. Apnimed’s New Drug Application for AD109 was assigned a Prescription Drug User Fee Act goal date of February 28, 2027.

Visit us at Apnimed.com and follow us on LinkedIn and X

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain disclosures that contain “forward-looking statements,” including, without limitation, statements regarding Apnimed’s expectations as to our commercial readiness, the clinical and therapeutic potential of AD109 (including to address OSA), and the occurrence and timing of the PDUFA goal date for AD109.

Forward-looking statements are based on Apnimed’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, the risks inherent in biopharmaceutical product development. These and other risks and uncertainties are described more fully in the sections titled “Risk Factors” of the final prospectus related to the offering filed with the SEC and in its most recent periodic report filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and Apnimed undertakes no duty to update such information except as required under applicable law.

Media Contact:
media@apnimed.com  

Investor Contact: 
ir@apnimed.com

CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) — Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced that on October 1, 2026, the compensation committee of Apnimed’s board of directors granted 19 new non-executive employees non-qualified stock options to purchase an aggregate of 481,300 shares of the Company’s common stock under Apnimed’s 2026 Inducement Plan (the “Plan”). Each stock option granted has an exercise price per share of $22.54, which is equal to Apnimed’s closing trading price on the grant date. One-fourth of the shares underlying each of the employee’s stock options will vest on the first anniversary of each employee’s start date and in equal monthly installments thereafter for the next three years, subject to such employee’s continued employment with the Company on such vesting dates.

The above-described awards were granted as an inducement material to such employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted pursuant to the terms of the Plan. The Plan was adopted by Apnimed’s board of directors on August 21, 2026.

About Apnimed, Inc.

Apnimed is a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases. Apnimed believes the introduction of once-nightly oral drugs has the potential to expand diagnosis and the reach of treatment for people with obstructive sleep apnea (“OSA”). Apnimed believes that people with OSA would benefit from having multiple drugs with differing mechanisms to more fully address the heterogeneity of OSA’s disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment and help more people get the oxygen and restorative sleep needed to thrive.

Apnimed is advancing its product candidate, AD109, designed to improve oxygenation in individuals living with OSA. Apnimed believes that AD109 could become the catalyst for a new oral treatment paradigm for OSA that has been historically limited to cumbersome devices or invasive surgeries. AD109 has completed two Phase 3 clinical trials for the treatment of mild, moderate and severe OSA. Apnimed’s New Drug Application for AD109 was assigned a Prescription Drug User Fee Act goal date of February 28, 2027.

Visit us at Apnimed.com and follow us on LinkedIn and X

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain disclosures that contain “forward-looking statements,” including, without limitation, statements regarding Apnimed’s expectations as to our commercial readiness, the clinical and therapeutic potential of AD109 (including to address OSA), and the occurrence and timing of the PDUFA goal date for AD109.

Forward-looking statements are based on Apnimed’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, the risks inherent in biopharmaceutical product development. These and other risks and uncertainties are described more fully in the sections titled “Risk Factors” of the final prospectus related to the offering filed with the SEC and in its most recent periodic report filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and Apnimed undertakes no duty to update such information except as required under applicable law.

Media Contact:
media@apnimed.com  

Investor Contact: 
ir@apnimed.com

CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) — Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced that on October 1, 2026, the compensation committee of Apnimed’s board of directors granted 19 new non-executive employees non-qualified stock options to purchase an aggregate of 481,300 shares of the Company’s common stock under Apnimed’s 2026 Inducement Plan (the “Plan”). Each stock option granted has an exercise price per share of $22.54, which is equal to Apnimed’s closing trading price on the grant date. One-fourth of the shares underlying each of the employee’s stock options will vest on the first anniversary of each employee’s start date and in equal monthly installments thereafter for the next three years, subject to such employee’s continued employment with the Company on such vesting dates.

The above-described awards were granted as an inducement material to such employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted pursuant to the terms of the Plan. The Plan was adopted by Apnimed’s board of directors on August 21, 2026.

About Apnimed, Inc.

Apnimed is a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases. Apnimed believes the introduction of once-nightly oral drugs has the potential to expand diagnosis and the reach of treatment for people with obstructive sleep apnea (“OSA”). Apnimed believes that people with OSA would benefit from having multiple drugs with differing mechanisms to more fully address the heterogeneity of OSA’s disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment and help more people get the oxygen and restorative sleep needed to thrive.

Apnimed is advancing its product candidate, AD109, designed to improve oxygenation in individuals living with OSA. Apnimed believes that AD109 could become the catalyst for a new oral treatment paradigm for OSA that has been historically limited to cumbersome devices or invasive surgeries. AD109 has completed two Phase 3 clinical trials for the treatment of mild, moderate and severe OSA. Apnimed’s New Drug Application for AD109 was assigned a Prescription Drug User Fee Act goal date of February 28, 2027.

Visit us at Apnimed.com and follow us on LinkedIn and X

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain disclosures that contain “forward-looking statements,” including, without limitation, statements regarding Apnimed’s expectations as to our commercial readiness, the clinical and therapeutic potential of AD109 (including to address OSA), and the occurrence and timing of the PDUFA goal date for AD109.

Forward-looking statements are based on Apnimed’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, the risks inherent in biopharmaceutical product development. These and other risks and uncertainties are described more fully in the sections titled “Risk Factors” of the final prospectus related to the offering filed with the SEC and in its most recent periodic report filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and Apnimed undertakes no duty to update such information except as required under applicable law.

Media Contact:
media@apnimed.com  

Investor Contact: 
ir@apnimed.com

MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for October 2026 of $0.08 per share, comprised of a $0.04 per share base dividend and $0.04 per share supplemental dividend, payable on November 2, 2026 to stockholders of record as of October 15, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company’s periodic report filed with the Securities and Exchange Commission.

ABOUT PENNANTPARK INVESTMENT CORPORATION

PennantPark Investment Corporation is a business development company which primarily invests in U.S. middle-market private companies in the form of first lien secured debt, second lien secured debt, subordinated debt and equity investments. PennantPark Investment Corporation is managed by PennantPark Investment Advisers, LLC.

ABOUT PENNANTPARK INVESTMENT ADVISERS, LLC

PennantPark Investment Advisers, LLC, a leading middle market credit platform, and its affiliates, manage over $10 billion of investable capital, including potential leverage. Since its inception in 2007, PennantPark Investment Advisers, LLC has provided investors access to middle market credit by offering private equity firms and their portfolio companies as well as other middle-market borrowers a comprehensive range of creative and flexible financing solutions. PennantPark Investment Advisers, LLC is headquartered in Miami and has offices in New York, Chicago, Houston, Los Angeles, Amsterdam, and Zurich. For more information about PennantPark and affiliates, please go to our website at www.pennantpark.com.

FORWARD-LOOKING STATEMENTS

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You should understand that under Section 27A(b)(2)(B) of the Securities Act and Section 21E(b)(2)(B) of the Exchange Act the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 do not apply to forward-looking statements made in periodic reports PennantPark Investment Corporation files under the Exchange Act. All statements other than statements of historical facts included in this press release are forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission. PennantPark Investment Corporation undertakes no duty to update any forward-looking statement made herein. You should not place undue influence on such forward-looking statements as such statements speak only as of the date on which they are made.

CONTACT:
Richard T. Allorto, Jr.
PennantPark Investment Corporation
(212) 905-1000
www.pennantpark.com

MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for October 2026 of $0.08 per share, comprised of a $0.04 per share base dividend and $0.04 per share supplemental dividend, payable on November 2, 2026 to stockholders of record as of October 15, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company’s periodic report filed with the Securities and Exchange Commission.

ABOUT PENNANTPARK INVESTMENT CORPORATION

PennantPark Investment Corporation is a business development company which primarily invests in U.S. middle-market private companies in the form of first lien secured debt, second lien secured debt, subordinated debt and equity investments. PennantPark Investment Corporation is managed by PennantPark Investment Advisers, LLC.

ABOUT PENNANTPARK INVESTMENT ADVISERS, LLC

PennantPark Investment Advisers, LLC, a leading middle market credit platform, and its affiliates, manage over $10 billion of investable capital, including potential leverage. Since its inception in 2007, PennantPark Investment Advisers, LLC has provided investors access to middle market credit by offering private equity firms and their portfolio companies as well as other middle-market borrowers a comprehensive range of creative and flexible financing solutions. PennantPark Investment Advisers, LLC is headquartered in Miami and has offices in New York, Chicago, Houston, Los Angeles, Amsterdam, and Zurich. For more information about PennantPark and affiliates, please go to our website at www.pennantpark.com.

FORWARD-LOOKING STATEMENTS

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You should understand that under Section 27A(b)(2)(B) of the Securities Act and Section 21E(b)(2)(B) of the Exchange Act the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 do not apply to forward-looking statements made in periodic reports PennantPark Investment Corporation files under the Exchange Act. All statements other than statements of historical facts included in this press release are forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission. PennantPark Investment Corporation undertakes no duty to update any forward-looking statement made herein. You should not place undue influence on such forward-looking statements as such statements speak only as of the date on which they are made.

CONTACT:
Richard T. Allorto, Jr.
PennantPark Investment Corporation
(212) 905-1000
www.pennantpark.com